Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Plant-Based Material Designed to Replace Plastics

Uses of plant-based material

Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics

Low Cost Vaccine, Patch Device Produce Immune Responses

Vaccine patch

Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses

Plant-Based Lipids Developed for mRNA Vaccines

Vesicles

Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines

Moderna Expands Vaccine Research, Mfring in Asia

Syringe and three vials

Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia

New Biotech Developing Synthetic Long-Term RNA

Avak Kahvejian

A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA. . . . → Read More: New Biotech Developing Synthetic Long-Term RNA

Cell Therapy Mfring Company Raises $82M in Venture Funds

T-cells and cancer cells

A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds

Biomanufacturing Materials Company Issues $500M IPO

Wall Street sign

Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO

Concrete Mfring Processes Win CO2 Conversion Challenge

Gaurav Sant

Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products. . . . → Read More: Concrete Mfring Processes Win CO2 Conversion Challenge

Synthetic DNA Company Raises $24M in Early Funds

DNA illustration

A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds

Infographic – Covax Begins Vaccine Deliveries

Chart: Covax deliveries

Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries